You have 9 free searches left this month | for more free features.

ER

Showing 26 - 50 of 8,314

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial (K-001, K-877-ER, CSG452)

Not yet recruiting
  • Healthy
  • (no location specified)
Feb 1, 2023

Dental Caries Trial in Jeddah (Er:YAG laser system (Doctor smile, Pluser, Italy), Master Torque high/low-speed air rotor

Completed
  • Dental Caries
  • Er:YAG laser system (Doctor smile, Pluser, Italy)
  • Master Torque high/low-speed air rotor handpiece (KaVo Dental, Charlotte, North Carolina, USA)
  • Jeddah, Saudi Arabia
    King Abdulaziz University
Jun 17, 2023

Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Breast Cancer, Neoadjuvant Trial in Wuhan (pyrotinib,Trastuzumab,carboplatin,Albumin paclitaxel)

Recruiting
  • Breast Cancer
  • Neoadjuvant
  • pyrotinib,Trastuzumab,carboplatin,Albumin paclitaxel
  • Wuhan, Hubei, China
  • +1 more
Aug 18, 2023

Acne Scars - Mixed Atrophic and Hypertrophic Trial in Lisboa (Alma Harmony)

Not yet recruiting
  • Acne Scars - Mixed Atrophic and Hypertrophic
  • Alma Harmony
  • Lisboa, Portugal
    Up Clinic
Oct 21, 2023

Pharmacokinetics Trial in Fargo (PrimeC-ER 748 mg, Ciprofloxacin 750 MG, Celecoxib 200mg)

Completed
  • Pharmacokinetics
  • PrimeC-ER 748 mg
  • +2 more
  • Fargo, North Dakota
    Novum
Oct 23, 2022

Viral Wart Trial in Haifa (Long-Pulsed Nd:YAG Laser 1064nm & Er:YAG Laser 2940nm, Er:YAG Laser 2940nm)

Completed
  • Viral Wart
  • Long-Pulsed Nd:YAG Laser 1064nm & Er:YAG Laser 2940nm
  • Er:YAG Laser 2940nm
  • Haifa, Israel
    Rambam Health Care Campus
Mar 14, 2023

Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

Active, not recruiting
  • Metastatic Breast Cancer
  • Springfield, Massachusetts
  • +2 more
Nov 1, 2022

Pulp and Periapical Tissue Disease, Pulp Necroses, Pulp; Granuloma Trial in Cairo (Conventional group (NaOCl/EDTA), Dual laser

Completed
  • Pulp and Periapical Tissue Disease
  • +2 more
  • Conventional group (NaOCl/EDTA)
  • +2 more
  • Cairo, Abbassia, Egypt
    Ain Shams University
Jul 25, 2023

ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer Trial in Luoyang, Shanghai (TFX06 tablet)

Recruiting
  • ER+, HER2- Advanced Breast Cancer
  • Metastatic Breast Cancer
  • TFX06 tablet
  • Luoyang, Henan, China
  • +1 more
Jun 25, 2023

Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • Milademetan
  • Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
  • Paris, France
    Institut Curie
Jun 27, 2023

Emotion Regulation, Mental Wellness Trial in Nicosia (Emotion Regulation Course)

Recruiting
  • Emotion Regulation
  • Mental Wellness
  • Emotion Regulation Course
  • Nicosia, Cyprus
    University of Cyprus
Feb 17, 2023

Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

Not yet recruiting
  • Breast Cancer
  • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
  • Ottawa, Ontario, Canada
  • +1 more
Jul 22, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Acne, Atrophic Scar Trial in Hangzhou (a fractional 1064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) picosecond laser

Completed
  • Acne
  • Atrophic Scar
  • a fractional 1064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) picosecond laser with MLA handpiece
  • a ablative fractional 2940-nm Er:YAG laser
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Jan 9, 2023

HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving

Completed
  • Breast Neoplasms
  • NET or NCT
  • Haidian, Beijing, China
    Peking University Cancer Hospital
Dec 30, 2022

Breast Cancer Trial (Giredestrant, Giredestrant plus triptorelin, Anastrozole plus triptorelin)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 13, 2023

Cannabis Use Trial in New York (guanfacine-ER, Placebo)

Recruiting
  • Cannabis Use
  • New York, New York
    STARS Clinic at Columbia and NYSPI Department of Psychiatry
Jun 6, 2022

Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))

Completed
  • Advanced Cancer
  • CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
  • Taichung, Taiwan
  • +1 more
Nov 25, 2022

Fluid Volume in Patients With Refractory Hypotension (Fresh-ER)

Completed
  • Undifferentated Shock
  • Starling SV
  • Denver, Colorado
    Denver Health Medical Center
Jan 6, 2023

Breast Cancer Trial (RP-6306, Gemcitabine, Observation)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 26, 2023

Aerosol Disease, Caries,Dental Trial in Wroclaw (Caries treatment with a dental turbine, Caries treatment with Er:YAG laser)

Completed
  • Aerosol Disease
  • Caries,Dental
  • Caries treatment with a dental turbine
  • Caries treatment with Er:YAG laser
  • Wroclaw, Poland
    Oral Surgery Department
Aug 3, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Mar 7, 2023

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Recruiting
  • Breast Cancer
  • +2 more
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 12, 2022

    Pain, Chronic Trial (Empowered Relief)

    Not yet recruiting
    • Pain, Chronic
    • Empowered Relief
    • (no location specified)
    Jun 27, 2023